{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:33:06Z","timestamp":1790015586809,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"GSK","award":["ETMF-219353"],"award-info":[{"award-number":["ETMF-219353"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40121-024-01060-8","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T02:02:29Z","timestamp":1730167349000},"page":"2563-2579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Life After Invasive Meningococcal Disease: Insights from Survivors and Their Caregivers"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-999X","authenticated-orcid":false,"given":"Oscar","family":"Herrera-Restrepo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3048-2704","authenticated-orcid":false,"given":"Nuzhat","family":"Afroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3184-2855","authenticated-orcid":false,"given":"Eliazar Sabater","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2918-722X","authenticated-orcid":false,"given":"Matthew","family":"Reaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-2435","authenticated-orcid":false,"given":"France Ginchereau","family":"Sowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-8316","authenticated-orcid":false,"given":"Ramiya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0295-7752","authenticated-orcid":false,"given":"Alicia","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6091-6314","authenticated-orcid":false,"given":"Patti","family":"Wukovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4867-8615","authenticated-orcid":false,"given":"Mariana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7758-6706","authenticated-orcid":false,"given":"Sofia B.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-3389","authenticated-orcid":false,"given":"Zeki","family":"Kocaata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1811-7684","authenticated-orcid":false,"given":"Obinna","family":"Onwude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"1060_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01061-7","author":"O Herrera-Restrepo","year":"2024","unstructured":"Herrera-Restrepo O, Afroz N, Sabater Cabrera E, et al. Initial experiences with invasive meningococcal disease: Insights from survivors and their caregivers. Infect Dis Ther. 2024. https:\/\/doi.org\/10.1007\/s40121-024-01061-7","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1060_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/21645515.2018.1507261","volume":"15","author":"C Stein-Zamir","year":"2019","unstructured":"Stein-Zamir C, Shoob H, Abramson N, et al. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines. Hum Vaccin Immunother. 2019;15(1):242\u20138.","journal-title":"Hum Vaccin Immunother"},{"key":"1060_CR3","unstructured":"Centers for Disease Control and Prevention. About meningococcal disease [updated 2024 Feb 1]. https:\/\/www.cdc.gov\/meningococcal\/about\/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fmeningococcal%2Fabout%2Fprevention.html. Accessed 2024 Oct 8."},{"key":"1060_CR4","unstructured":"Centers for Disease Control and Prevention. Meningococcal disease symptoms and complications [updated 2024 Aug 30]. https:\/\/www.cdc.gov\/meningococcal\/symptoms\/index.html. Accessed 2024 Oct 8."},{"issue":"4","key":"1060_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","volume":"81","author":"SR Parikh","year":"2020","unstructured":"Parikh SR, Campbell H, Bettinger JA, et al. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020;81(4):483\u201398.","journal-title":"J Infect"},{"key":"1060_CR6","unstructured":"Centers for Disease Control and Prevention. ACIP Recommendations [updated 2024 Aug 29]. https:\/\/www.cdc.gov\/acip\/vaccine-recommendations\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html. Accessed 2024 Oct 8."},{"issue":"9","key":"1060_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","volume":"69","author":"SA Mbaeyi","year":"2020","unstructured":"Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(9):1\u201341.","journal-title":"MMWR Recomm Rep"},{"issue":"33","key":"1060_CR8","doi-asserted-by":"publisher","first-page":"708","DOI":"10.15585\/mmwr.mm7333a1","volume":"73","author":"C Pingali","year":"2023","unstructured":"Pingali C, Yankey D, Chen M, et al. National vaccination coverage among adolescents aged 13\u201317 years\u2014national immunization survey-teen, United States, 2023. MMWR Morb Mortal Wkly Rep. 2024;73(33);708\u201314.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1060_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40121-021-00546-z","volume":"11","author":"J Shen","year":"2022","unstructured":"Shen J, Bou\u00e9e S, Aris E, Emery C, Beck EC. Long-Term mortality and state financial support in invasive meningococcal disease \u2013 real-world data analysis using the French National Claims Database (SNIIRAM). Infect Dis Ther. 2022;11(1):249\u201362.","journal-title":"Infect Dis Ther"},{"issue":"8","key":"1060_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037168","volume":"10","author":"E Scanferla","year":"2020","unstructured":"Scanferla E, Fasse L, Gorwood P. Subjective experience of meningitis survivors: a transversal qualitative study using interpretative phenomenological analysis. BMJ Open. 2020;10(8):e037168.","journal-title":"BMJ Open"},{"issue":"4","key":"1060_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","volume":"7","author":"KJ Olbrich","year":"2018","unstructured":"Olbrich KJ, M\u00fcller D, Schumacher S, et al. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421\u201338.","journal-title":"Infect Dis Ther"},{"issue":"1","key":"1060_CR12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","volume":"22","author":"J Shen","year":"2022","unstructured":"Shen J, Begum N, Ruiz-Garcia Y, et al. Range of invasive meningococcal disease sequelae and health economic application \u2013 a systematic and clinical review. BMC Public Health. 2022;22(1):1078.","journal-title":"BMC Public Health"},{"issue":"4","key":"1060_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4161\/hv.7.4.14434","volume":"7","author":"KL Davis","year":"2011","unstructured":"Davis KL, Misurski D, Miller J, Karve S. Cost impact of complications in meningococcal disease: evidence from a United States managed care population. Hum Vaccin. 2011;7(4):458\u201365.","journal-title":"Hum Vaccin"},{"key":"1060_CR14","doi-asserted-by":"crossref","unstructured":"Adil SM, Hodges SE, Charalambous LT, et al. Paediatric bacterial meningitis in the USA: outcomes and healthcare resource utilization of nosocomial versus community-acquired infection. J Med Microbiol. 2021;70(1).","DOI":"10.1099\/jmm.0.001276"},{"issue":"1","key":"1060_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12883-017-0983-2","volume":"17","author":"B Schoser","year":"2017","unstructured":"Schoser B, Bilder DA, Dimmock D, et al. The humanistic burden of Pompe disease: are there still unmet needs? A systematic review. BMC Neurol. 2017;17(1):202.","journal-title":"BMC Neurol"},{"key":"1060_CR16","unstructured":"American Society for Meningitis Prevention (formerly the Meningitis B Action Project). 2024 [updated 2024]. https:\/\/meningitisprevention.org\/. Accessed 2024 Mar 26."},{"key":"1060_CR17","doi-asserted-by":"crossref","unstructured":"Herrera-Restrepo O, Afroz N, Barrio J, Sabater E, Onwude O. Concept elicitation to understand invasive meningococcal disease burden of illness from a patient and caregiver perspective. Poster presented at: Pediatric Academic Societies Annual Meeting; April 27\u2013May\u00a01; Washington, D.C. 2023.","DOI":"10.1016\/j.jval.2024.03.2029"},{"issue":"1","key":"1060_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/01.PCC.0000144705.81825.EE","volume":"6","author":"D Shears","year":"2005","unstructured":"Shears D, Nadel S, Gledhill J, Garralda ME. Short-term psychiatric adjustment of children and their parents following meningococcal disease. Pediatr Crit Care Med. 2005;6(1):39\u201343.","journal-title":"Pediatr Crit Care Med"},{"issue":"13\u201314","key":"1060_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3109\/02699052.2011.613090","volume":"25","author":"R Sumpter","year":"2011","unstructured":"Sumpter R, Brunklaus A, McWilliam R, Dorris L. Health-related quality-of-life and behavioural outcome in survivors of childhood meningitis. Brain Inj. 2011;25(13\u201314):1288\u201395.","journal-title":"Brain Inj"},{"issue":"5","key":"1060_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/adc.88.5.395","volume":"88","author":"S Halket","year":"2003","unstructured":"Halket S, de Louvois J, Holt DE, Harvey D. Long term follow up after meningitis in infancy: behaviour of teenagers. Arch Dis Child. 2003;88(5):395\u20138.","journal-title":"Arch Dis Child"},{"issue":"9","key":"1060_CR21","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S1474-4422(12)70180-1","volume":"11","author":"RM Viner","year":"2012","unstructured":"Viner RM, Booy R, Johnson H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11(9):774\u201383.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1060_CR22","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1111\/apa.12112","volume":"102","author":"F Sweeney","year":"2013","unstructured":"Sweeney F, Viner RM, Booy R, Christie D. Parents\u2019 experiences of support during and after their child\u2019s diagnosis of meningococcal disease. Acta Paediatr. 2013;102(3):e126\u201330.","journal-title":"Acta Paediatr"},{"issue":"3","key":"1060_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/13638490400022246","volume":"8","author":"TR Ehrlich","year":"2005","unstructured":"Ehrlich TR, von Rosenstiel IA, Grootenhuis MA, Gerrits AI, Bos AP. Long-term psychological distress in parents of child survivors of severe meningococcal disease. Pediatr Rehabil. 2005;8(3):220\u20134.","journal-title":"Pediatr Rehabil"},{"key":"1060_CR24","unstructured":"Shah H, Herrera-Restrepo O, Juttla G, et al. Market and non-market productivity losses associated with invasive meningococcal disease (IMD) in the United States (US). In: Poster Presented at: European Society for Paediatric Infectious Diseases 42nd Annual Meeting; May\u00a020\u201324; Copenhagen, Denmark. 2024."},{"issue":"3","key":"1060_CR25","doi-asserted-by":"publisher","first-page":"e502","DOI":"10.1542\/peds.2008-0581","volume":"123","author":"J Borg","year":"2009","unstructured":"Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123(3):e502\u20139.","journal-title":"Pediatrics"},{"issue":"10","key":"1060_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s40273-018-0679-5","volume":"36","author":"B Wang","year":"2018","unstructured":"Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: a global systematic review. Pharmacoeconomics. 2018;36(10):1201\u201322.","journal-title":"Pharmacoeconomics"},{"key":"1060_CR27","unstructured":"World Health Organization. Preventing and controlling meningitis outbreaks. https:\/\/www.who.int\/activities\/preventing-and-controlling-meningitis-outbreaks. Accessed 2024 Mar 28."},{"key":"1060_CR28","unstructured":"Centers for Disease Control and Prevention. Meningococcal vaccination [updated 2024 Jun 2024]. https:\/\/www.cdc.gov\/meningococcal\/vaccines\/index.html. Accessed 2024 Oct 8."},{"key":"1060_CR29","unstructured":"Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18\u00a0years or younger 2024 [updated 2024 Jun 27]. https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/schedules\/downloads\/child\/0-18yrs-child-combined-schedule.pdf. Accessed 2024 Oct 8."},{"issue":"4","key":"1060_CR30","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1097\/INF.0000000000003455","volume":"41","author":"ER Packnett","year":"2022","unstructured":"Packnett ER, Zimmerman NM, Kim G, et al. A real-world claims data analysis of meningococcal serogroup B vaccine series completion and potential missed opportunities in the United States. Pediatr Infect Dis J. 2022;41(4):e158\u201365.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1060_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29030","volume":"68","author":"MJ Ehrhardt","year":"2021","unstructured":"Ehrhardt MJ, Williams AM, Liu Q, et al. Cumulative burden of chronic health conditions among adolescent and young adult survivors of childhood cancer: identification of vulnerable groups at key medical transitions. Pediatr Blood Cancer. 2021;68(6):e29030.","journal-title":"Pediatr Blood Cancer"},{"key":"1060_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.51866\/oa.138","volume":"18","author":"P Chaknum","year":"2023","unstructured":"Chaknum P, Harniratisai T, Somprasert C, Chiang LC. Perception of the factors contributing to family happiness among caregivers of stroke survivors in a suburban community in Thailand: a qualitative study. Malays Fam Physician. 2023;18:13.","journal-title":"Malays Fam Physician"},{"issue":"1","key":"1060_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12904-020-00572-7","volume":"19","author":"DH Ferreira","year":"2020","unstructured":"Ferreira DH, Kochovska S, Honson A, Phillips JL, Currow DC. Two faces of the same coin: a qualitative study of patients\u2019 and carers\u2019 coexistence with chronic breathlessness associated with chronic obstructive pulmonary disease (COPD). BMC Palliat Care. 2020;19(1):64.","journal-title":"BMC Palliat Care"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01060-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01060-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01060-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T15:09:31Z","timestamp":1732201771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01060-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1060"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01060-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"11 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Oscar Herrera-Restrepo, Eliazar Sabater Cabrera, and Zeki Kocaata are employees and stockholders of GSK; Sofia B. Pinto is an employee of GSK. Matthew Reaney, France Ginchereau Sowell, Ramiya Kumar, and Obinna Onwude are employees of IQVIA, which was paid by GSK to conduct this study. Nuzhat Afroz is a current employee of Novo Nordisk, and was an employee of IQVIA during the time the study was conducted. Alicia Stillman, Patti Wukovits, and Mariana Rodrigues are affiliated with the American Society for Meningitis Prevention (formerly the Meningitis B Action Project), which receives educational grants from GSK and Pfizer via the Kimberly Coffey Foundation and the Emily Stillman Foundation. Alicia Stillman, Patti Wukovits, and Mariana Rodrigues received no payment for recruitment and were blinded to any identifiable information from recruited participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the study protocol, the Guidelines for Good Pharmacoepidemiology Practices published by the International Society of Pharmacoepidemiology, the ethical principles of the Declaration of Helsinki, and IRB requirements. IRB approval was sought and obtained from the USA-based WCG IRB. Participants and the study sponsor were blinded from each other (i.e., participants were not aware of the study sponsor and only directly interacted with the investigators, and the study sponsor was not aware of any participant identifying information at any point during study conduct). All participants\u2009\u2265\u200918\u00a0years old provided informed consent prior to their participation in the research study; participants\u2009<\u200918\u00a0years\u00a0old provided assent, in addition to consent from their caregiver\/legal guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}